FR1655M - Médicament présentant notamment des propriétés anti-acéthylcholiniques, psychotropes et stimulantes, a base d'éthers de benzhydrols substitués par un groupe fluorométhyle. - Google Patents

Médicament présentant notamment des propriétés anti-acéthylcholiniques, psychotropes et stimulantes, a base d'éthers de benzhydrols substitués par un groupe fluorométhyle.

Info

Publication number
FR1655M
FR1655M FR882014A FR882014A FR1655M FR 1655 M FR1655 M FR 1655M FR 882014 A FR882014 A FR 882014A FR 882014 A FR882014 A FR 882014A FR 1655 M FR1655 M FR 1655M
Authority
FR
France
Prior art keywords
acethylcholinic
benzhydrol
psychotropic
medicinal product
fluoromethyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR882014A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Pharmaceutische Fabrieken NV
Original Assignee
Koninklijke Pharmaceutische Fabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Pharmaceutische Fabrieken NV filed Critical Koninklijke Pharmaceutische Fabrieken NV
Application granted granted Critical
Publication of FR1655M publication Critical patent/FR1655M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/08—Diarylmethoxy radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR882014A 1960-12-19 1961-12-14 Médicament présentant notamment des propriétés anti-acéthylcholiniques, psychotropes et stimulantes, a base d'éthers de benzhydrols substitués par un groupe fluorométhyle. Active FR1655M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL259219 1960-12-19

Publications (1)

Publication Number Publication Date
FR1655M true FR1655M (fr) 1963-01-14

Family

ID=19752768

Family Applications (1)

Application Number Title Priority Date Filing Date
FR882014A Active FR1655M (fr) 1960-12-19 1961-12-14 Médicament présentant notamment des propriétés anti-acéthylcholiniques, psychotropes et stimulantes, a base d'éthers de benzhydrols substitués par un groupe fluorométhyle.

Country Status (6)

Country Link
CH (1) CH420201A (OSRAM)
DE (1) DE1185195B (OSRAM)
ES (1) ES273042A1 (OSRAM)
FR (1) FR1655M (OSRAM)
GB (1) GB965293A (OSRAM)
NL (1) NL111445C (OSRAM)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1087618B (de) * 1952-04-08 1960-08-25 Konink Pharmaceutischie Fabrie Verfahren zur Herstellung von neuen lokalanaesthesierend und atropinwirksamen Dialkylaminoalkyl-(benzhydryl)-aethern
GB751197A (en) * 1953-09-09 1956-06-27 Dow Chemical Co (-a-trifluoromethylbenzhydryloxy) trialkylamines and their salts

Also Published As

Publication number Publication date
DE1185195B (de) 1965-01-14
GB965293A (en) 1964-07-29
CH420201A (de) 1966-09-15
ES273042A1 (es) 1962-07-01
NL111445C (OSRAM)

Similar Documents

Publication Publication Date Title
FR3760M (fr) Médicament a base de dérivés de la 1.2.3.6-tétrahydropyridine, ayant notamment des propriétés analgésiques et anti-tussives.
Berndtson Semblance, symbol, and expression in the aesthetics of Susanne Langer
FR1655M (fr) Médicament présentant notamment des propriétés anti-acéthylcholiniques, psychotropes et stimulantes, a base d&#39;éthers de benzhydrols substitués par un groupe fluorométhyle.
FR2463M (fr) Médicament a base d&#39;un dérivé de la 2.4-diaminopyrido[2.3-d]-pyrimidine, utilisable notamment contre les infections microbiennes.
GB1251530A (OSRAM)
BE586007A (fr) Para-N,N&#39;-quinacridones linéaires et leur procédé de préparation.
FR1411M (fr) Médicament a propriétés sédatives et d&#39;épargne protidique a base de 4-hydroxy-butyrate de lysine.
FR2955M (fr) Médicament utilisable notamment comme analgésique et hypnotique a base de 4-alcoylamidophénylcarbonates d&#39;haloalcoyle.
FR379M (fr) Médicament a propriétés hypnotiques et sédatives, a base d&#39;(orthohydroxyphényl) 2-oxadiazole-1,3,4.
FR1577M (fr) Médicament présentant notamment des propriétés diurétiques et cardiotoniques a base de vitexoside.
FR1004M (fr) Composition hypnotique et tranquillisante contenant la 4,6-diméthylpyridazone-3.
CA603789A (en) 11.beta.,14.alpha.,17.alpha.,21-TETRAHYDROXYPROGESTERONE AND PREPARATION THEREOF
Foster Jr Race Relations and American Law
FR1807M (fr) Médicament présentant notamment des propriétés sédatives et hypnogenes a base de ω (n-morpholino)p-chloro-acétophénone.
FR3460M (fr) Médicament présentant notamment des propriétés bradycardisantes a base de o-diéthylamino-éthoxy-2-phényl-2-indole.
FR3640M (fr) 1 pyridil-cyclopropane-2-substitués par des groupements organiques, notamment utiles comme sédatifs, tranquillisants et anti-dépresseurs.
AU273206B2 (en) Epihalohydrin-polyalkylenepolyamine condensation products, their preparation and use
FR3462M (fr) Médicament utilisable, en particulier, comme spasmolytique et anesthésique local, a base d&#39;ester de cyclohexanol substitué.
BE600340A (fr) Nouvelles 1.2-diaryl-3.5-dioxo-pyrazolidines substituées en position 4 et leur préparation.
CA597381A (en) 6.beta.,19-SELENO-1-DEHYDROTESTOSTERONE AND ESTERS THEREOF
CA540730A (en) 17.alpha.-METHYL-17.beta.-HYDROXYANDROSTANE-3,6-DIONE AND PREPARATION
CA552019A (en) 5.alpha.,6.beta.,21-TRIHYDROXY-3,11,20-TRIKETOPREGNANE AND DERIVATIVES THEREOF
CA552022A (en) 5.alpha.,6.beta.,21-TRIHYDROXY-3,11,20-TRIKETOPREGNENE-6-ACETATE-21-ACYLATE AND DERIVATIVES THEREOF
CA611151A (en) 4,5,6-trichloroisophthalic acid and preparation thereof
FR113M (fr) Produit myorésolutif, analgésique et sédatif.